Why faecal transplants could bring hope to patients with cirrhosis

A landmark trial has shown that a faecal transplant can treat advanced liver disease and fight antimicrobial resistance. The findings, which were announced at the EASL Congress in Vienna, showed that a faecal microbiota transplant (FMT) can dramatically improve gut health, and provide another much-needed treatment option for patients with advanced cirrhosis (scarring of the liver). “FMT involves taking a stool from a healthy individual and transplanting it into somebody that has a disease, in this case, liver disease,”  said Dr Lindsey Edwards, co-leader of the study and Honorary Senior Lecturer in the Department of Inflammation Biology at King’s College